These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1688514)

  • 21. On the search for new anticancer drugs 14: the plasma pharmacokinetics and tissue distribution of spin-labeled thio-TEPA (SL-O-TT).
    Gutierrez PL; Cohen BE; Sosnovsky G; Davis TA; Egorin MJ
    Cancer Chemother Pharmacol; 1985; 15(3):185-91. PubMed ID: 2996798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 32p-labeled thio-tepa absorption in normal rat bladders: potential guide for intravesical chemotherapy in bladder cancer.
    Puchner PJ; Veenema RJ; Tomashefsky P; Pinzus T; Tannenbaum T
    Urology; 1974 Jul; 4(1):33-6. PubMed ID: 21322979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accuracy, feasibility, and clinical impact of prospective Bayesian pharmacokinetically guided dosing of cyclophosphamide, thiotepa, and carboplatin in high-dose chemotherapy.
    de Jonge ME; Huitema AD; Tukker AC; van Dam SM; Rodenhuis S; Beijnen JH
    Clin Cancer Res; 2005 Jan; 11(1):273-83. PubMed ID: 15671556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II trial of thio-TEPA in relapsed and refractory ovarian carcinoma.
    Langer CJ; Nash S; Catalano R; Rosenblum NG; Hogan WM; Comis RL; O'Dwyer PJ
    Gynecol Oncol; 1991 Dec; 43(3):242-6. PubMed ID: 1752494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pharmacokinetic and clinical evaluation of thio-TEPA in combination with cisplatin as first-line chemotherapy for advanced epithelial ovarian carcinoma.
    Hagen B; Onsrud M; Dale O
    Int J Gynecol Cancer; 1999 Mar; 9(2):110-116. PubMed ID: 11240751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The binding of thio-TEPA in human serum and to isolated serum protein fractions.
    Hagen B; Nilsen OG
    Cancer Chemother Pharmacol; 1987; 20(4):319-23. PubMed ID: 3121202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous quantification of cyclophosphamide, 4-hydroxycyclophosphamide, N,N',N"-triethylenethiophosphoramide (thiotepa) and N,N',N"-triethylenephosphoramide (tepa) in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
    de Jonge ME; van Dam SM; Hillebrand MJ; Rosing H; Huitema AD; Rodenhuis S; Beijnen JH
    J Mass Spectrom; 2004 Mar; 39(3):262-71. PubMed ID: 15039933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stability of thioTEPA and its metabolites, TEPA, monochloroTEPA and thioTEPA-mercapturate, in plasma and urine.
    van Maanen MJ; Doesburg Smits K; Damen JM; Heck AJ; Beijnen JH
    Int J Pharm; 2000 May; 200(2):187-94. PubMed ID: 10867248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I evaluation of thio-TEPA in combination with cisplatin for advanced gynecologic malignancies.
    Sandles LG; Freedman RS; Raber MN; Kavanagh J; Edwards CL; Scott WR; Wharton JT
    Gynecol Oncol; 1990 Nov; 39(2):139-45. PubMed ID: 2121628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chromosomal aberrations induced by thio-TEPA in cells of malignant ovarian tumors in humans].
    Neĭshtadt EL; Gnilevskaia ZU; Aĭnbinder NM
    Vopr Onkol; 1975; 21(7):48-53. PubMed ID: 814712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of N, N' N"-triethylenethiophosphoramide, N, N"-triethylenephosphoramide, cyclophosphamide, and 4-hydroxy-cyclophosphamide in microvolume human plasma to support neonatal and pediatric drug studies.
    Huang L; Winger BA; Cheah V; Gingrich D; Marzan F; Lu Y; Cooper JC; Aweeka F; Long-Boyle J
    J Chromatogr Open; 2022 Nov; 2():. PubMed ID: 35875822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ThioTEPA pharmacokinetics during intravesical chemotherapy: the influence of dose and volume of instillate on systemic uptake and dose rate to the tumour.
    Masters JR; McDermott BJ; Harland S; Bibby MC; Loadman PM
    Cancer Chemother Pharmacol; 1996; 38(1):59-64. PubMed ID: 8603453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of a therapeutic drug monitoring strategy for thiotepa in a high-dose chemotherapy regimen.
    Huitema AD; Mathôt RA; Tibben MM; Rodenhuis S; Beijnen JH
    Ther Drug Monit; 2001 Dec; 23(6):650-7. PubMed ID: 11802099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose escalation of N,N',N"-triethylenethiophosphoramide combined with pentoxifylline for advanced breast cancer.
    Shapiro CL; Dezube BJ; Tretyakov O; Wright J; Cap B; Henderson IC; Hayes DF
    Clin Cancer Res; 1995 Aug; 1(8):791-6. PubMed ID: 9816047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of intravesical thio-tepa on normal and tumor urothelium.
    Nieh PT; Daly JJ; Heaney JA; Heney NM; Prout GR
    J Urol; 1978 Jan; 119(1):59-61. PubMed ID: 413937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thiono compounds. 4. In vitro mutagenic and antineoplastic activity of TEPA and thio-TEPA.
    Breau AP; Field L; Mitchell WM
    Cell Biol Toxicol; 1984 Oct; 1(1):21-30. PubMed ID: 6086064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival of patients with high grade glioma treated with intrathecal thiotriethylenephosphoramide for ependymal or leptomeningeal gliomatosis.
    Witham TF; Fukui MB; Meltzer CC; Burns R; Kondziolka D; Bozik ME
    Cancer; 1999 Oct; 86(7):1347-53. PubMed ID: 10506724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A longitudinal study of patients with superficial bladder carcinoma successfully treated with weekly intravesical thio-tepa.
    Nocks BN; Nieh PT; Prout GR
    J Urol; 1979 Jul; 122(1):27-9. PubMed ID: 110947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase I study of thiotepa administered by short-term and protracted continuous intravenous infusion.
    Lokich JJ; Egorin MJ; Cohen BE; Bern MM; Zipoli TE; Moore C
    Cancer; 1989 Jan; 63(1):46-50. PubMed ID: 2491952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fertility regulation in male rats and hamsters with alkylating agents.
    Howe GR; Steward R
    Contraception; 1980 Aug; 22(2):175-81. PubMed ID: 6160950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.